Globus Medical (GMED) Financials

Globus Medical Inc (GMED) is a medical device company that specializes in the design, development, and commercialization of musculoskeletal implants and related technologies. The company's products are used in the treatment of spinal disorders, trauma, and orthopedic surgeries. Globus Medical Inc (GMED) offers a wide range of products, including spinal fusion implants, spinal fixation devices, biologics, and surgical instruments. The company generates revenue through the sale of its products to hospitals, ambulatory surgery centers, and other healthcare providers. As of December 31, 2020, Globus Medical Inc (GMED) had total revenue of $824.3 million. Gross profit for the same period was $564.8 million. Net income from stockholders was $203.6 million. EBIT (earnings before interest and taxes) was $205.7 million, while EBITDA (earnings before interest, taxes, depreciation, and amortization) was $290.4 million.

The balance sheet of Globus Medical Inc (GMED) as of December 31, 2020, showed that the company had total assets of $2.07 billion. Total liabilities were $697.7 million, and stockholders' equity was $1.37 billion. Cash equivalents for the period were $173.3 million, and net debt was $18 million. The company's financial statements also indicate that it had positive operating cash flow of $293.8 million, investing cash flow of -$206.3 million, and financing cash flow of -$47.2 million. Free cash flow, a measure of a company's ability to generate cash after accounting for capital expenditures, was $87.5 million for the same period. These financials demonstrate the strong financial position of Globus Medical Inc (GMED) and its ability to generate revenue and cash flow from its operations.